Earlier this year, Greece became the latest EU country to make medical cannabis products available to patients. In February 2024,
As part of its European expansion, CBD of Denver has announced that its wholly owned subsidiary, Luxora, has signed four
The European CBD Report: Health & Wellness has been published by Prohibition Partners and sponsored by Atalis.Â
The companies have stated the LOI positions each to take advantage of potential German adult use legalisation within their respective supply chain verticals.Â
The restructuring initiative is expected to save the company USD$7 million by the end of 2023.
Linnea will begin producing GMP-certified high-THC APIs in 2023.
The UK-based pharmaceutical company has stated that the registration follows seven harvests and extractions and an MHRA inspection in 2022.
Ambrani CBD is expanding its distribution to the continent with a focus on brick-and-mortar retail in Germany.
Flora Growth has provided an update to its international commercial cannabis export business.
The application has been submitted in preparation for a review.
We won’t spam you
© 2024 Prohibition Holdings Ltd. All Rights Reserved.
